Hemoglobin Calais [beta 76 (E20) Ala----Pro]: a hemoglobin variant with decreased intrinsic oxygen affinity. 1990

H Wajcman, and J Kister, and M Marden, and B Bohn, and Y Blouquit, and J Descamps, and M Goudemand, and C Poyart, and F Galacteros
INSERM U299, Hôpital de Bicêtre, Le Kremlin Bicêtre, France.

Hb Calais [beta 76 (E20) Ala----Pro] is a new human hemoglobin variant displaying a decreased oxygen affinity. The only electrophoretical difference with Hb A was a slightly more acidic isoelectric point. A 2-fold decrease in the oxygen affinity was found by equilibrium measurements performed in a suspension of intact red blood cells and in the lysate. It was confirmed by kinetic studies of the purified abnormal hemoglobin. The rate of methemoglobin formation at 37 degrees C of Hb Calais was also increased relative to Hb A. The mechanism by which the Pro for Ala substitution of an external residue in the beta-chains results in these profound functional abnormalities is unclear. Subtle changes at the heme pocket, at a distance from the mutation, may be a plausible explanation for the effects observed.

UI MeSH Term Description Entries
D007526 Isoelectric Point The pH in solutions of proteins and related compounds at which the dipolar ions are at a maximum. Isoelectric Points,Point, Isoelectric,Points, Isoelectric
D008706 Methemoglobin Ferrihemoglobin
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011995 Recombination, Genetic Production of new arrangements of DNA by various mechanisms such as assortment and segregation, CROSSING OVER; GENE CONVERSION; GENETIC TRANSFORMATION; GENETIC CONJUGATION; GENETIC TRANSDUCTION; or mixed infection of viruses. Genetic Recombination,Recombination,Genetic Recombinations,Recombinations,Recombinations, Genetic
D005260 Female Females
D006455 Hemoglobins, Abnormal Hemoglobins characterized by structural alterations within the molecule. The alteration can be either absence, addition or substitution of one or more amino acids in the globin part of the molecule at selected positions in the polypeptide chains. Abnormal Hemoglobins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Wajcman, and J Kister, and M Marden, and B Bohn, and Y Blouquit, and J Descamps, and M Goudemand, and C Poyart, and F Galacteros
January 2006, Hemoglobin,
H Wajcman, and J Kister, and M Marden, and B Bohn, and Y Blouquit, and J Descamps, and M Goudemand, and C Poyart, and F Galacteros
January 1987, Hemoglobin,
H Wajcman, and J Kister, and M Marden, and B Bohn, and Y Blouquit, and J Descamps, and M Goudemand, and C Poyart, and F Galacteros
April 1981, Blood,
H Wajcman, and J Kister, and M Marden, and B Bohn, and Y Blouquit, and J Descamps, and M Goudemand, and C Poyart, and F Galacteros
November 2004, American journal of hematology,
H Wajcman, and J Kister, and M Marden, and B Bohn, and Y Blouquit, and J Descamps, and M Goudemand, and C Poyart, and F Galacteros
January 1991, Hemoglobin,
H Wajcman, and J Kister, and M Marden, and B Bohn, and Y Blouquit, and J Descamps, and M Goudemand, and C Poyart, and F Galacteros
July 1979, Blood,
H Wajcman, and J Kister, and M Marden, and B Bohn, and Y Blouquit, and J Descamps, and M Goudemand, and C Poyart, and F Galacteros
January 1998, Hemoglobin,
H Wajcman, and J Kister, and M Marden, and B Bohn, and Y Blouquit, and J Descamps, and M Goudemand, and C Poyart, and F Galacteros
April 1974, Blood,
H Wajcman, and J Kister, and M Marden, and B Bohn, and Y Blouquit, and J Descamps, and M Goudemand, and C Poyart, and F Galacteros
October 1987, FEBS letters,
H Wajcman, and J Kister, and M Marden, and B Bohn, and Y Blouquit, and J Descamps, and M Goudemand, and C Poyart, and F Galacteros
August 1980, Blood,
Copied contents to your clipboard!